Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. (Q53305562)

13 May 2018

title

Persistent clinical response to the anti-TNF-alpha antibody infliximab in patients with ankylosing spondylitis over 3 years. (English)

1 reference

13 May 2018

0 references

0 references

0 references

1 reference

ankylosing spondylitis

1 reference

Braun J

1

1 reference

13 May 2018

Baraliakos X

2

1 reference

13 May 2018

Brandt J

3

1 reference

13 May 2018

Listing J

4

1 reference

13 May 2018

Zink A

5

1 reference

13 May 2018

Alten R

6

1 reference

13 May 2018

Burmester G

7

1 reference

13 May 2018

Gromnica-Ihle E

8

1 reference

13 May 2018

Kellner H

9

1 reference

13 May 2018

Schneider M

10

1 reference

13 May 2018

Sörensen H

11

1 reference

13 May 2018

Zeidler H

12

1 reference

13 May 2018

Sieper J

13

1 reference

13 May 2018

publication date

9 March 2005

1 reference

13 May 2018

published in

Rheumatology

1 reference

13 May 2018

volume

44

1 reference

13 May 2018

issue

5

1 reference

13 May 2018

page(s)

670-676

1 reference

13 May 2018

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors

cites work

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromsø, northern Norway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Functional disability predicts total costs in patients with ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Work status and productivity costs due to ankylosing spondylitis: comparison of three European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

New treatment options in spondyloarthropathies: increasing evidence for significant efficacy of anti-tumor necrosis factor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Two year maintenance of efficacy and safety of infliximab in the treatment of ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Development and preselection of criteria for short term improvement after anti-TNF alpha treatment in ankylosing spondylitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

Biological therapies in the spondyloarthritides--the current state

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FRHEUMATOLOGY%2FKEH584

10.1093/RHEUMATOLOGY/KEH584

21 January 2018

Identifiers

DOI

1 reference

13 May 2018

1 reference

13 May 2018